This oxidant appears to simultaneously trigger NLRP3 activation and matrix metalloproteinase (MMP) pathways, thereby amplifying BBB breakdown, accelerating HT formation and worsening outcomes in hyperglycaemic stroke patients [29]. This evidence concerns the gene NLRP3 and stroke disorder.